IBD Stock Of The Day Tests New Buy Point As Indicators Suggest More Upside
Mizuho analysts raised its price target ahead of Cardinal Health's earnings. The stock is testing a buy point after topping another entry.
The post IBD Stock Of The Day Tests New Buy Point As Indicators Suggest More Upside appeared first on Investor's Business Daily .